Novomics Co., Ltd. (XKON: 283100)
South Korea flag South Korea · Delayed Price · Currency is KRW
541.00
0.00 (0.00%)
At close: Nov 18, 2024

Novomics Statistics

Total Valuation

Novomics has a market cap or net worth of KRW 3.59 billion.

Market Cap 3.59B
Enterprise Value n/a

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Novomics has 6.53 million shares outstanding.

Current Share Class n/a
Shares Outstanding 6.53M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 37.62%
Owned by Institutions (%) 4.29%
Float 3.79M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 17.44
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.09

Current Ratio 3.09
Quick Ratio 2.94
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.71
Interest Coverage -13.00

Financial Efficiency

Return on equity (ROE) is -1,403.46% and return on invested capital (ROIC) is -97.73%.

Return on Equity (ROE) -1,403.46%
Return on Assets (ROA) -43.27%
Return on Capital (ROIC) -97.73%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.03
Inventory Turnover 2.32

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.23% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -84.23%
50-Day Moving Average 641.40
200-Day Moving Average 975.51
Relative Strength Index (RSI) 44.71
Average Volume (20 Days) 2,645

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Novomics had revenue of KRW 206.03 million and -3.42 billion in losses. Loss per share was -523.33.

Revenue 206.03M
Gross Profit 45.13M
Operating Income -5.30B
Pretax Income -3.42B
Net Income -3.42B
EBITDA -4.60B
EBIT -5.30B
Loss Per Share -523.33
Full Income Statement

Balance Sheet

The company has 1.72 billion in cash and 3.17 billion in debt, giving a net cash position of -1.45 billion or -221.80 per share.

Cash & Cash Equivalents 1.72B
Total Debt 3.17B
Net Cash -1.45B
Net Cash Per Share -221.80
Equity (Book Value) -1.44B
Book Value Per Share -220.01
Working Capital 1.34B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.45 billion and capital expenditures -1.49 million, giving a free cash flow of -4.45 billion.

Operating Cash Flow -4.45B
Capital Expenditures -1.49M
Free Cash Flow -4.45B
FCF Per Share -681.64
Full Cash Flow Statement

Margins

Gross Margin 21.91%
Operating Margin -2,574.77%
Pretax Margin -1,659.01%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -2,160.91%

Dividends & Yields

Novomics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -142.67%
Shareholder Yield -142.67%
Earnings Yield -95.15%
FCF Yield -123.94%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Novomics has an Altman Z-Score of -26.45. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -26.45
Piotroski F-Score n/a